ABSTRACT
Both immediate and delayed hypersensitivity reactions to iodinated contrast media (ICM) are relatively common. However, there are few data to determine the clinical utility of immunologic evaluation of ICM. To evaluate the utility of ICM skin testing in patients with ICM hypersensitivity, 23 patients (17 immediate and 6 delayed reactions) were enrolled from 3 university hospitals in Korea. With 6 commonly used ICM including iopromide, iohexol, ioversol, iomeprol, iopamidol and iodixanol, skin prick (SPT), intradermal (IDT) and patch tests were performed. Of 10 patients with anaphylaxis, 3 (30.0%) and 6 (60.0%) were positive respectively on SPTs and IDTs with the culprit ICM. Three of 6 patients with urticaria showed positive IDTs. In total, 11 (64.7%) had positive on either SPT or IDT. Three of 6 patients with delayed rashes had positive response to patch test and/or delayed IDT. Among 5 patients (3 anaphylaxis, 1 urticaria and 1 delayed rash) taken subsequent radiological examinations, 3 patients administered safe alternatives according to the results of skin testing had no adverse reaction. However, anaphylaxis developed in the other 2 patients administered the culprit ICM again. With 64.7% (11/17) and 50% (3/6) of the sensitivities of corresponding allergic skin tests with culprit ICM for immediate and delayed hypersensitivity reactions, the present study suggests that skin tests is useful for the diagnosis of ICM hypersensitivity and for selecting safe ICM and preventing a recurrence of anaphylaxis caused by the same ICM.
Subject(s)
Female , Humans , Male , Middle Aged , Anaphylaxis/chemically induced , Contrast Media/adverse effects , Cross Reactions/immunology , Dermatitis, Contact/diagnosis , Drug Hypersensitivity/diagnosis , Iodides/immunology , Iohexol/analogs & derivatives , Iopamidol/analogs & derivatives , Republic of Korea , Skin Tests/methods , Triiodobenzoic Acids , Urticaria/diagnosisABSTRACT
A pulmonary artery aneurysm is a common manifestation and the leading cause of mortality in Behcet's disease. We describe a case of spontaneous rupture of a pulmonary artery aneurysm that, due to the inadequacy of medical therapy and the disadvantages of surgery, became the ideal candidate for endovascular management and was successfully performed by using the Amplatzer Vascular Plug 4.
Subject(s)
Adult , Humans , Male , Aneurysm, Ruptured/diagnostic imaging , Behcet Syndrome/complications , Iopamidol/analogs & derivatives , Pulmonary Artery , Radiography, Thoracic , Septal Occluder Device , Tomography, X-Ray ComputedABSTRACT
OBJECTIVE: We aimed to describe the imaging findings of multidetector CT coronary angiography (MDCTA) in cases of vasospastic angina (VA) and to determine the accuracy of MDCTA in the identification of VA as compared with invasive coronary angiography with an ergonovine provocation test (CAG with an EG test). MATERIALS AND METHODS: Fifty-three patients with clinically suspected VA were enrolled in this study. Two radiologists analyzed the stenosis degree, presence or absence of plaque, plaque composition, and a remodeling index of the related-segment in CAG with an EG test, which were used as a gold standard. We evaluated the diagnostic performances of MDCTA by comparing the MDCTA findings with those of CAG with an EG test. RESULTS: Among the 25 patients with positive CAG with an EG test, all 12 patients with significant stenosis showed no definite plaque with the negative arterial remodeling. Of the six patients with insignificant stenosis, three (50%) had non-calcified plaque (NCP), two (33%) had mixed plaque, and one (17%) had calcified plaque. When the criteria for significant stenosis with negative remodeling but no definite evidence of plaque as a characteristic finding of MDCTA were used, results showed sensitivities, specificities, positive predictive values (PPV), and negative predictive values (NPV) of 48%, 100%, 100%, and 68%, respectively. CONCLUSION: Significant stenosis with negative remodeling, but no definite evidence of plaque, is the characteristic finding on MDCTA of VA. Cardiac MDCTA shows good diagnostic performance with high specificity and PPV as compared with CAG with an EG test.
Subject(s)
Female , Humans , Male , Middle Aged , Angina Pectoris/diagnostic imaging , Chi-Square Distribution , Comorbidity , Contrast Media , Coronary Angiography/methods , Electrocardiography , Ergonovine , Iopamidol/analogs & derivatives , Oxytocics , Predictive Value of Tests , Radiographic Image Interpretation, Computer-Assisted , Retrospective Studies , Sensitivity and Specificity , Tomography, X-Ray Computed/methodsABSTRACT
The present study was performed to determine the effect of combined intravenous and oral volume supplementation on the incidence of contrast-induced nephropathy [CIN] in patients undergoing percutaneous coronary intervention [PCI]. Consecutive patients [n = 958] receiving iomeprol 350 during PCI were evaluated prospectively for the development of CIN. All patients received protocol-defined intravenous and oral volume supplementation. CIN was defined as an increase in serum creatinine of at least 44 micromol/l within 48 h. Of the 958 patients enrolled in the study, 147 [15%] were diabetic and 107 [11%] had stage III renal disease. The average baseline glomerular filtration rate was 88 +/- 25 ml/min/1.73 m[2]. During the intervention an average of 238 +/- 86 ml of contrast medium was administered. CIN developed in 13 of 958 [1.4%; 95% confidence interval 0.6-2.1%] patients. The incidence of CIN was low even in predefined risk subgroups [women: 2.4%, diabetics: 2.7%, patients with stage III kidney disease: 6.5%]. The incidence of CIN is low when preprocedural fluid volume supplementation is used